Exome sequencing identifies MAX mutations as a cause of hereditary pheochromocytoma

Alberto Cascón, Mercedes Robledo and colleagues show that MAX germline mutations confer susceptibility to hereditary pheochromocytoma. This finding supports a key role for MAX and its interaction partners in tumors of neural crest cell origin. Hereditary pheochromocytoma (PCC) is often caused by ger...

Full description

Saved in:
Bibliographic Details
Published inNature genetics Vol. 43; no. 7; pp. 663 - 667
Main Authors Comino-Méndez, Iñaki, Gracia-Aznárez, Francisco J, Schiavi, Francesca, Landa, Iñigo, Leandro-García, Luis J, Letón, Rocío, Honrado, Emiliano, Ramos-Medina, Rocío, Caronia, Daniela, Pita, Guillermo, Gómez-Graña, Álvaro, de Cubas, Aguirre A, Inglada-Pérez, Lucía, Maliszewska, Agnieszka, Taschin, Elisa, Bobisse, Sara, Pica, Giuseppe, Loli, Paola, Hernández-Lavado, Rafael, Díaz, José A, Gómez-Morales, Mercedes, González-Neira, Anna, Roncador, Giovanna, Rodríguez-Antona, Cristina, Benítez, Javier, Mannelli, Massimo, Opocher, Giuseppe, Robledo, Mercedes, Cascón, Alberto
Format Journal Article
LanguageEnglish
Published New York Nature Publishing Group US 01.07.2011
Nature Publishing Group
Subjects
Online AccessGet full text
ISSN1061-4036
1546-1718
1546-1718
DOI10.1038/ng.861

Cover

More Information
Summary:Alberto Cascón, Mercedes Robledo and colleagues show that MAX germline mutations confer susceptibility to hereditary pheochromocytoma. This finding supports a key role for MAX and its interaction partners in tumors of neural crest cell origin. Hereditary pheochromocytoma (PCC) is often caused by germline mutations in one of nine susceptibility genes described to date 1 , 2 , 3 , 4 , but there are familial cases without mutations in these known genes. We sequenced the exomes of three unrelated individuals with hereditary PCC (cases) and identified mutations in MAX , the MYC associated factor X gene. Absence of MAX protein in the tumors and loss of heterozygosity caused by uniparental disomy supported the involvement of MAX alterations in the disease. A follow-up study of a selected series of 59 cases with PCC identified five additional MAX mutations and suggested an association with malignant outcome and preferential paternal transmission of MAX mutations. The involvement of the MYC-MAX-MXD1 network in the development and progression of neural crest cell tumors is further supported by the lack of functional MAX in rat PCC (PC12) cells 5 and by the amplification of MYCN in neuroblastoma 6 and suggests that loss of MAX function is correlated with metastatic potential.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 14
ObjectType-Article-1
ObjectType-Feature-2
content type line 23
ISSN:1061-4036
1546-1718
1546-1718
DOI:10.1038/ng.861